厄洛替尼或吉非替尼治疗非小细胞肺癌。
Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
机构信息
Louisiana State University Health Sciences Center and Hematology-Oncology Clinic, Baton Rouge, LA 70805, USA.
出版信息
N Engl J Med. 2011 Mar 10;364(10):947-55. doi: 10.1056/NEJMct0807960.
PMID:21388312
Abstract
A 64-year-old woman receives the diagnosis of metastatic non-small-cell lung cancer (NSCLC), which has progressed during treatment with carboplatin, paclitaxel, and bevacizumab. Erlotinib therapy is recommended.
摘要
一位 64 岁女性被诊断患有转移性非小细胞肺癌（NSCLC），在接受卡铂、紫杉醇和贝伐珠单抗治疗期间病情进展。建议使用厄洛替尼治疗。
Zotero 插件